Henrik Hasman1, Philip T L C Clausen2, Hülya Kaya1, Frank Hansen1, Jenny Dahl Knudsen3, Mikala Wang4, Barbara Juliane Holzknecht5, Jurgita Samulioniené6, Bent L Røder7, Niels Frimodt-Møller3, Ole Lund2, Anette M Hammerum1. 1. Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark. 2. Department of Genomic Epidemiology, National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark. 3. Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark. 4. Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark. 5. Department of Clinical Microbiology, Herlev and Gentofte Hospital, Herlev, Denmark. 6. Department of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark. 7. Department of Clinical Microbiology, Slagelse Hospital, Slagelse, Denmark.
Abstract
OBJECTIVES: In enterococci, resistance to linezolid is often mediated by mutations in the V domain of the 23S rRNA gene (G2576T or G2505A). Furthermore, four genes [optrA, cfr, cfr(B) and poxtA] encode linezolid resistance in enterococci. We aimed to develop a Web tool for detection of the two mutations and the four genes encoding linezolid resistance in enterococci from whole-genome sequence data. METHODS: LRE-Finder (where LRE stands for linezolid-resistant enterococci) detected the fraction of Ts in position 2576 and the fraction of As in position 2505 of the 23S rRNA and the cfr, cfr(B), optrA and poxtA genes by aligning raw sequencing reads (fastq format) with k-mer alignment. For evaluation, fastq files from 21 LRE isolates were submitted to LRE-Finder. As negative controls, fastq files from 1473 non-LRE isolates were submitted to LRE-Finder. The MICs of linezolid were determined for the 21 LRE isolates. As LRE-negative controls, 26 VRE isolates were additionally selected for linezolid MIC determination. RESULTS: LRE-Finder was validated and showed 100% concordance with phenotypic susceptibility testing. A cut-off of 10% mutations in position 2576 and/or position 2505 was set in LRE-Finder for predicting a linezolid resistance phenotype. This cut-off allows for detection of a single mutated 23S allele in both Enterococcus faecalis and Enterococcus faecium, while ignoring low-level sequencing noise. CONCLUSIONS: A Web tool for detection of the 23S rRNA mutations (G2576T and G2505A) and the optrA, cfr, cfr(B) and poxtA genes from whole-genome sequences from enterococci is now available online.
OBJECTIVES: In enterococci, resistance to linezolid is often mediated by mutations in the V domain of the 23S rRNA gene (G2576T or G2505A). Furthermore, four genes [optrA, cfr, cfr(B) and poxtA] encode linezolid resistance in enterococci. We aimed to develop a Web tool for detection of the two mutations and the four genes encoding linezolid resistance in enterococci from whole-genome sequence data. METHODS: LRE-Finder (where LRE stands for linezolid-resistant enterococci) detected the fraction of Ts in position 2576 and the fraction of As in position 2505 of the 23S rRNA and the cfr, cfr(B), optrA and poxtA genes by aligning raw sequencing reads (fastq format) with k-mer alignment. For evaluation, fastq files from 21 LRE isolates were submitted to LRE-Finder. As negative controls, fastq files from 1473 non-LRE isolates were submitted to LRE-Finder. The MICs of linezolid were determined for the 21 LRE isolates. As LRE-negative controls, 26 VRE isolates were additionally selected for linezolid MIC determination. RESULTS: LRE-Finder was validated and showed 100% concordance with phenotypic susceptibility testing. A cut-off of 10% mutations in position 2576 and/or position 2505 was set in LRE-Finder for predicting a linezolid resistance phenotype. This cut-off allows for detection of a single mutated 23S allele in both Enterococcus faecalis and Enterococcus faecium, while ignoring low-level sequencing noise. CONCLUSIONS: A Web tool for detection of the 23S rRNA mutations (G2576T and G2505A) and the optrA, cfr, cfr(B) and poxtA genes from whole-genome sequences from enterococci is now available online.
Authors: Sarah A Egan; Anna C Shore; Brian O'Connell; Grainne I Brennan; David C Coleman Journal: J Antimicrob Chemother Date: 2020-07-01 Impact factor: 5.790
Authors: Rene S Hendriksen; Valeria Bortolaia; Heather Tate; Gregory H Tyson; Frank M Aarestrup; Patrick F McDermott Journal: Front Public Health Date: 2019-09-04
Authors: Eric Wenzler; Maressa Santarossa; Kevin A Meyer; Amanda T Harrington; Gail E Reid; Nina M Clark; Fritzie S Albarillo; Zackery P Bulman Journal: Open Forum Infect Dis Date: 2020-01-04 Impact factor: 3.835
Authors: Stefan Schwarz; Wanjiang Zhang; Xiang-Dang Du; Henrike Krüger; Andrea T Feßler; Shizhen Ma; Yao Zhu; Congming Wu; Jianzhong Shen; Yang Wang Journal: Clin Microbiol Rev Date: 2021-06-02 Impact factor: 50.129
Authors: Gayatri Shankar Chilambi; Hayley R Nordstrom; Daniel R Evans; Jose A Ferrolino; Randall T Hayden; Gabriela M Marón; Anh N Vo; Michael S Gilmore; Joshua Wolf; Jason W Rosch; Daria Van Tyne Journal: Proc Natl Acad Sci U S A Date: 2020-05-11 Impact factor: 11.205
Authors: Yifan Wu; Run Fan; Yinchao Wang; Lei Lei; Andrea T Feßler; Zheng Wang; Congming Wu; Stefan Schwarz; Yang Wang Journal: Sci Rep Date: 2019-10-29 Impact factor: 4.379
Authors: Valeria Bortolaia; Rolf S Kaas; Etienne Ruppe; Marilyn C Roberts; Stefan Schwarz; Vincent Cattoir; Alain Philippon; Rosa L Allesoe; Ana Rita Rebelo; Alfred Ferrer Florensa; Linda Fagelhauer; Trinad Chakraborty; Bernd Neumann; Guido Werner; Jennifer K Bender; Kerstin Stingl; Minh Nguyen; Jasmine Coppens; Basil Britto Xavier; Surbhi Malhotra-Kumar; Henrik Westh; Mette Pinholt; Muna F Anjum; Nicholas A Duggett; Isabelle Kempf; Suvi Nykäsenoja; Satu Olkkola; Kinga Wieczorek; Ana Amaro; Lurdes Clemente; Joël Mossong; Serge Losch; Catherine Ragimbeau; Ole Lund; Frank M Aarestrup Journal: J Antimicrob Chemother Date: 2020-12-01 Impact factor: 5.790